PREBLICK RYAN (Chief Financial Officer) received a stock award from INDIVIOR PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/12/2026ACC: 0002014866-26-000004
Officer· Chief Financial Officer
Since Mar 2026
+150.87K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
150.87K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+37.36K
Price / share
—
Trade value
—
% of position
13.3%
2/10/2026
280.58K→317.94K
Total
Net shares
+37.36K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/10/2026 | A · Award | +37.36K | — | — | 13.3% | 280.58K | 317.94K |
| Total | +37.36K | $0.00 | ||||||
Derivative Transactions1
Performance Stock Units
Direct
Converts to
Common Stock
113.51K shares
Shares
+113.51K
Strike price
0
Held after
113.51K
Exercisable
—
2/9/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Performance Stock Units Direct | Common Stock113.51K shares | 2/9/2026 | A · Award | +113.51K | 0 | — | 113.51K |